Research hints that hidden risks might accompany long-term use of the medicines that treat attention-deficit hyperactivity disorder
Get weekly coverage delivered to your inbox.
YES! Send me a free issue of Scientific American with no obligation to continue the subscription. If I like it, I will be billed for the one-year subscription.
